Development and Validation of a High-Performance Liquid Chromatography Assay for Voriconazole-Reference-Cited by-同舟云学术

Development and Validation of a High-Performance Liquid Chromatography Assay for Voriconazole

Published:2003-07 Issue:7 Volume:47 Page:2348-2350
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Pennick Gennethel J.¹,Clark Martin²,Sutton Deanna A.¹,Rinaldi Michael G.¹³

Affiliation:

1. Department of Pathology, University of Texas Health Science Center at San Antonio

2. Pfizer Limited, Sandwich, United Kingdom

3. Audie Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas

Abstract

ABSTRACT An analytical method for the determination of voriconazole (UK-109,496; Pfizer) in plasma was developed and validated. The method utilizes solid-phase extraction technology and high-performance liquid chromatography. The lower limit of quantitation is 0.2 μg/ml, and the range of linearity tested was 0.2 to 10 μg/ml.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.47.7.2348-2350.2003

Reference6 articles.

1. NCCLS. 1999. Evaluation of precision performance of clinical chemistry devices: approved guidelines. Approved guidelines document EP5-A no. 2. NCCLS Wayne Pa.

2. NCCLS. 2001. Evaluation of the linearity of quantitative analytical method; proposed guidelines—second edition. EP6-P2 vol. 21 no. 20. NCCLS Wayne Pa.

3. NCCLS. 1999. Statistical quality control for quantitative measurements: principles and definition: approved guidelines document C24-A2 vol. 19 no. 5 second ed. NCCLS Wayne Pa.

4. Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in Plasma

5. Shah, V., K. Midha, S. Dighe, I. McGilveray, J. Skelly, A. Yacobi, T. Layloff, C. Viswanathan, C. Cook, R. McDowall, K. Pittman, and S. Spector. 1992. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci.81:309-312.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development, optimization and validation of an analytical method for the determination of voriconazole in plasma by high-performance liquid chromatography-ultraviolet detection: Application for comprehensive study;Annales Pharmaceutiques Françaises;2024-09

2. Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole;Methods in Molecular Biology;2023-12-01

3. Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age;Mycoses;2023-08-08

4. Quantitative determination of voriconazole by thionine reduction and its potential application in a pharmaceutical and clinical setting;Analytical Methods;2023

5. High-Performance Liquid Chromatography for Ultra-Simple Determination of Plasma Voriconazole Concentration;Journal of Fungi;2022-09-29